简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2020-09-28 09:35 Clover Biopharmaceuticals Announces Formation of a Global Scientific Advisory Board for its COVID-19 Vaccine Program
2020-09-25 18:52 U.S. MRTP Authorization Pathway Explored in PMI’s Latest Scientific Update
2020-09-25 18:46 Careismatic Brands Launches “19 Days of Gratitude” Global Campaign to Support Nurses and the DAISY Foundation
2020-09-25 15:18 Clover Biopharmaceuticals Announces Positive Preclinical Data and Updates on Phase 1 Study for its Adjuvanted S-Trimer COVID-19 Vaccine Candidate
2020-09-25 10:19 BioDuro and Sundia Partner as an Industry Leading Contract Research, Development and Manufacturing Organization
2020-09-25 09:34 Science, Data, and Facts Should Unite Decision-Making, Says PMI CEO in Speech at Concordia Summit
2020-09-24 13:41 Vifor Pharma announces outcome of AFFIRM-AHF topline data
2020-09-24 12:21 Bioventus Reaches Milestone with 2 Million DUROLANE® Treatments Worldwide
2020-09-24 10:05 HKSTP Calls Innovators Worldwide to Join the Virtual Elevator Pitch Competition 2020
2020-09-24 10:02 Immetas Therapeutics Announces Series A Financing to Advance Research on Inflammation Pathways in Aging and Develop Therapeutics for Cancer and Inflammatory Disease
2020-09-23 14:16 Qihan Biotech Publishes First Clinical Xenotransplantation Prototype, ‘Pig 3.0’, in Nature Biomedical Engineering
2020-09-22 09:16 EpiFaith®, The Innovative Epidural Safeguard, Now Arrives in APAC Hospitals
2020-09-21 16:58 Takeda Presents New Data Highlighting Scientific Advancements in Lung Cancer at ESMO Virtual Congress
2020-09-21 09:43 Brii Biosciences Appoints Rogers Luo, Ankang Li To Leadership Positions
2020-09-18 14:48 Patient recruitment starts for the international PRO-SID study evaluating Panzyga® for primary prophylaxis in patients with chronic lymphocytic leukaemia and secondary immunodeficiency
2020-09-18 14:36 Vifor Pharma Group Announces Successful Sale of OM Pharma
2020-09-18 09:41 BOEHRINGER INGELHEIM AND MIRATI THERAPEUTICS ANNOUNCE CLINICAL COLLABORATION TO STUDY BI 1701963, A SOS1::PAN-KRAS INHIBITOR IN COMBINATION WITH MRTX849, A KRAS G12C SELECTIVE INHIBITOR
2020-09-17 14:20 Sir Richard Branson Joins Dr. Anthony Fauci and Dr. Sanjay Gupta as Keynote Speakers for Everbridge’s Virtual Symposium, COVID-19: Road to Recovery (R2R), October 14-15, 2020
2020-09-17 09:25 International WELL Building Institute Formally Launches WELL v2
2020-09-16 17:40 C3.ai Launches C3.ai COVID-19 Grand Challenge